Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Polysomnography Study of MK6096 in Patients With Primary Insomnia (6096-011)(COMPLETED)
This study has been completed.
Study NCT01021852 Information provided by Merck Sharp & Dohme Corp.
First Received on November 25, 2009. Last Updated on March 25, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Nervous System Diseases
Sleep Disorders, Intrinsic
Interventions listed in this trial
MK6096 2.5 mg and placebo
Comparator: MK6096 5 mg and placebo
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers